HOME PRODUCTS COMPANY CONTACT FAQ

Research Dictionary Pharma

Sign Up FREE or Login

NSC 668036

structure in first source

Also Known As:

NSC-668036; NSC668036

Networked: 2 relevant articles (1 outcomes, 2 trials/studies)

Relationship Network

Bio-Agent Context: Research Results

Polycyclic Compounds: 6
- Macrocyclic Compounds: 15
  - Cyclic Peptides: 530
    - Depsipeptides: 297
      - NSC 668036: 2
Amino Acids, Peptides, and Proteins: 1
- Peptides: 82426
  - Cyclic Peptides: 530
    - Depsipeptides: 297
      - NSC 668036: 2

Experts

1.	Resham, Kahkashan: 1 article (12/2019)
2.	Sharma, Shyam S: 1 article (12/2019)
3.	Cao, Honghui: 1 article (02/2015)
4.	Chen, Xiang: 1 article (02/2015)
5.	Dai, Jinghong: 1 article (02/2015)
6.	Gu, Shen: 1 article (02/2015)
7.	Han, Xiaodong: 1 article (02/2015)
8.	Li, Zutong: 1 article (02/2015)
9.	Qian, Weiping: 1 article (02/2015)
10.	Shi, Chaowen: 1 article (02/2015)

Related Diseases

1.	Pulmonary Fibrosis (Fibrosing Alveolitis) 02/01/2015 - "In this study, we determined the effects of transforming growth factor-beta (TGF-β) and Wnt/β-catenin signaling on myofibroblast differentiation of NIH/3T3 fibroblasts in vitro and evaluated the therapeutic efficacy of NSC668036 in bleomycin-induced pulmonary fibrosis murine model. "
2.	Neuralgia (Stump Neuralgia) 12/01/2019 - "In the present study, we have investigated the neuroprotective effects of Wnt signaling inhibitors namely LGK974 (Porcupine inhibitor), NSC668036 (Disheveled inhibitor) and PNU76454 (β-catenin inhibitor) in paclitaxel-induced neuropathic pain. "

Related Drugs and Biologics

1.	Catenins
2.	Transforming Growth Factor beta (TGF-beta)
3.	indium-bleomycin
4.	Neuroprotective Agents
5.	Paclitaxel (Taxol)
6.	LGK974